Complete Remission Of Rare Adenocarcinoma Of The Oropharynx With Apceden (R) (Dendritic Cell-Based Vaccine): A Case Report

Chaitanya Kumar,Sakshi Kohli,Srikanth Chiliveru,Minish Jain,Bandana Sharan

CLINICAL CASE REPORTS（2017）

引用 4|浏览5

暂无评分

摘要

APCEDEN is an autologous monocyte-derived dendritic cell-based immunotherapy. A 58-year-old man with adenocarcinoma of oropharynx shows complete remission after receiving APCEDEN in conjunction with Geftinib validated by reduction in size, whereas Gefitinib alone lead to disease progression.

查看译文

关键词

APCEDEN, dendritic cells, immunotherapy, oropharyngeal carcinoma, retromolar trigone

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要